ArticleFrontiers in oncology2025

Real-world efficacy and safety of inetetamab-based therapy in HER2-positive metastatic breast cancer patients with prior exposure to trastuzumab.

Yangyang Duan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.